Pfizer Expanding Production of COVID-19 Vaccine by 10%
Pfizer CEO says company expects to have delivered 220 million doses by end of May.
Tags: vaccine
Pfizer Vaccine Hopes Give Dow 800-Point Shot in the Arm
NEW YORK -- U.S. stocks rallied Monday but closed well below session highs after drugmakers Pfizer and BioNTech announced preliminary "success" in trials of a COVID-19 vaccine candidate.
U.S. Stock Futures Rise After Promising Vaccine Study
U.S. stock futures rose Wednesday as investors cheered promising results from the study of an experimental coronavirus vaccine while awaiting earnings from more of the nation’s biggest financial companies. Futures…
Investors Get Excited About Pfizer, BioNTech’s Coronavirus Vaccine Candidate
The path to a COVID-19 vaccine has started to come into view this week, following the stock-moving disclosures of early-stage clinical data for two vaccine candidates and a rigorous new…